Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug  | Reuters News Agency

It’s the most wonderful time of the year ― unless you’re on a diet and have set impossible standards for eating during the holidays. There’s nothing wrong with taking an “everything in moderation” approach at the dinner table, but other “rules” we establish for ourselves around the holidays can actually hinder rather than help our…

Like most workplace accidents, the tragedy that took place at a Wisconsin sawmill in June didn’t have to happen. In fact, Michael Schuls, a high school student who had turned 16 just weeks before his death, should never have been trying to unjam a stick stacker machine at Florence Hardwoods in the first place.  So…

If you want to refresh your beard grooming routine at home between barbershop appointments, the first upgrade you need is a quality trimmer to keep your facial hair in shape. Because there are tons out there to choose from, we asked real barbers to share the trimmers they actually use in their shops to get perfect results.  One…

Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…

The world is aging rapidly, and there are more and more ways to invest in this theme. Shams Afzal, managing director at Carnegie Investment Counsel, noted that 17% of the U.S. population is now over the age of 65, and that proportion is expected to grow higher. And the demographics of that age group is…

Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs, including its red-hot weight loss treatment Zepbound, to expand patient access.  The company’s direct-to-consumer push announced Thursday, the first of its kind for a big drugmaker,…